Beck Bode’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Beck Bode's EW Position: Q1 2022 in Review
Beck Bode sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 4,579 shares — an estimated $593K sold.
Beck Bode first reported a position in EW in Q4 2018 and held it in 12 quarters. The position peaked at $15.2M in Q3 2020. 1,313 funds tracked by Wall St. Rank hold EW as of Q1 2022.
- Beck Bode reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
- Beck Bode sold 4,579 Edwards Lifesciences shares in Q1 2022, an estimated $593K.
- Beck Bode first reported a position in Edwards Lifesciences in Q4 2018 and held it in 12 quarters.
- Beck Bode's Edwards Lifesciences position peaked at $15.2M in Q3 2020.
- 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.
Based on Beck Bode's 13F filing for Q1 2022, filed 2 May 2022.